Filter posts

New PhRMA report: Nearly 800 Cancer Medicines in Development

A new report from the Pharmaceutical Research and Manufacturers of America (PhRMA) shows that biopharma …

Washington Post: Why Extremely Expensive Drugs Are Often Worth the Cost

Jason Millman highlights a new study published in Health Affairs showing specialty drugs often provide …

Health Affairs: 5 Myths about Cancer Care in America

In the latest issue of Health Affairs, Dana Goldman of the University of Southern California …

Cancer drugs save and extend lives

This week, CBS aired a misleading segment on the cost of innovative cancer therapies. BIO …

5 Priorities for Reducing Infant Mortality

In the U.S., the number of babies who die in their first year of life …

New Treatments Needed for Obesity

ObesityWeek 2014, Nov. 2-7, in Boston Offers Opportunities to Learn & Connect Coauthored by The …

Patient and Venture Philanthropy Groups Presenting at 2014 BIO Investor Forum

BIO’s alliance development team works to foster collaboration between the biotech industry and nonprofit disease …

The Hill: In War on Cancer, Patients at Risk of Becoming Commoditized

Ted Okon, executive director of the Community Oncology Alliance, highlights the significant progress the medical …

Mito What???

Mitochondrial Disease: The Most Common Disease You’ve Probably Never Heard of… About 20 years ago, …

Playing Detective With Checkpoint Therapies

Three words are on the lips of everyone following new developments in cancer therapies: checkpoint inhibitor …